AVTX
Avalo Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$18.45-4.75%
Price as of Jul 20, 2026
AVTX earnings
Avalo Therapeutics, Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 6, 2026in NaN days
EPS est $-0.66 · Revenue est —
Track record
Beat EPS in 6 of 12 quarters
Avg surprise +3.1% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 13, 2026 | $-1.00 | $-0.98 | +2.0% | — | — |
| Mar 23, 2026 | $-1.54 | $-0.37 | +76.0% | $59000 | +0.0% |
| Nov 6, 2025 | $-1.67 | $-2.19 | -31.1% | — | — |
| Aug 7, 2025 | $-1.43 | $-1.92 | -34.3% | — | — |
| Mar 20, 2025 | $-0.39 | $-7.95 | -1938.5% | $192000 | — |
| Nov 7, 2024 | $-1.19 | $-2.83 | -137.8% | $249000 | — |
| Mar 29, 2024 | $-4.80 | $-116.21 | -2321.0% | $571000 | +90.3% |
| Nov 9, 2023 | $-261.90 | $-26.19 | +90.0% | $236000 | -21.3% |
| Aug 3, 2023 | $-214.29 | $-140.48 | +34.4% | $643000 | +28.6% |
| May 4, 2023 | $-230.95 | $-202.38 | +12.4% | $475000 | -52.5% |
| Aug 4, 2022 | $-428.57 | $-328.57 | +23.3% | $1M | -12.9% |
| May 5, 2022 | $-400.16 | $-571.66 | -42.9% | $1M | +81.7% |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-06.